Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 5
1947 12
1948 18
1949 18
1950 20
1951 16
1952 43
1953 35
1954 63
1955 60
1956 73
1957 59
1958 43
1959 59
1960 24
1961 26
1962 47
1963 39
1964 57
1965 39
1966 28
1967 72
1968 71
1969 82
1970 82
1971 121
1972 142
1973 160
1974 116
1975 99
1976 82
1977 93
1978 117
1979 107
1980 131
1981 197
1982 233
1983 226
1984 143
1985 112
1986 118
1987 95
1988 121
1989 107
1990 107
1991 104
1992 108
1993 117
1994 113
1995 133
1996 106
1997 143
1998 128
1999 182
2000 222
2001 278
2002 313
2003 324
2004 328
2005 407
2006 449
2007 501
2008 536
2009 485
2010 500
2011 615
2012 662
2013 647
2014 624
2015 627
2016 530
2017 514
2018 479
2019 318
2020 23
Text availability
Article attribute
Article type
Publication date

Search Results

13,267 results
Results by year
Filters applied: . Clear all
Page 1
Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice.
Gordon R, Albornoz EA, Christie DC, Langley MR, Kumar V, Mantovani S, Robertson AAB, Butler MS, Rowe DB, O'Neill LA, Kanthasamy AG, Schroder K, Cooper MA, Woodruff TM. Gordon R, et al. Sci Transl Med. 2018 Oct 31;10(465):eaah4066. doi: 10.1126/scitranslmed.aah4066. Sci Transl Med. 2018. PMID: 30381407 Free PMC article.
Recent developments and prospects of dioxins and furans remediation.
Rathna R, Varjani S, Nakkeeran E. Rathna R, et al. J Environ Manage. 2018 Oct 1;223:797-806. doi: 10.1016/j.jenvman.2018.06.095. Epub 2018 Jul 5. J Environ Manage. 2018. PMID: 29986327 Review.
Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation.
Yao C, Veleva T, Scott L Jr, Cao S, Li L, Chen G, Jeyabal P, Pan X, Alsina KM, Abu-Taha I Dr, Ghezelbash S, Reynolds CL, Shen YH, LeMaire SA, Schmitz W, Müller FU, El-Armouche A, Tony Eissa N, Beeton C, Nattel S, Wehrens XHT, Dobrev D, Li N. Yao C, et al. Circulation. 2018 Nov 13;138(20):2227-2242. doi: 10.1161/CIRCULATIONAHA.118.035202. Circulation. 2018. PMID: 29802206 Free PMC article.
IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer.
Wu TC, Xu K, Martinek J, Young RR, Banchereau R, George J, Turner J, Kim KI, Zurawski S, Wang X, Blankenship D, Brookes HM, Marches F, Obermoser G, Lavecchio E, Levin MK, Bae S, Chung CH, Smith JL, Cepika AM, Oxley KL, Snipes GJ, Banchereau J, Pascual V, O'Shaughnessy J, Palucka AK. Wu TC, et al. Cancer Res. 2018 Sep 15;78(18):5243-5258. doi: 10.1158/0008-5472.CAN-18-0413. Epub 2018 Jul 16. Cancer Res. 2018. PMID: 30012670 Free PMC article. Clinical Trial.
Molecular mechanisms of the action of Arctigenin in cancer.
He Y, Fan Q, Cai T, Huang W, Xie X, Wen Y, Shi Z. He Y, et al. Biomed Pharmacother. 2018 Dec;108:403-407. doi: 10.1016/j.biopha.2018.08.158. Epub 2018 Sep 17. Biomed Pharmacother. 2018. PMID: 30236849 Free article. Review.
A2AR Antagonism with CPI-444 Induces Antitumor Responses and Augments Efficacy to Anti-PD-(L)1 and Anti-CTLA-4 in Preclinical Models.
Willingham SB, Ho PY, Hotson A, Hill C, Piccione EC, Hsieh J, Liu L, Buggy JJ, McCaffery I, Miller RA. Willingham SB, et al. Cancer Immunol Res. 2018 Oct;6(10):1136-1149. doi: 10.1158/2326-6066.CIR-18-0056. Epub 2018 Aug 21. Cancer Immunol Res. 2018. PMID: 30131376 Free article.
13,267 results
Jump to page
Feedback